Hayri E. Balcioglu

Delft, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Publisher Correction: CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.

Publisher Correction: CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.

Journal: Communications biology
Published: July 01, 2026

Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in blood.

Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in blood.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 31, 2025

CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.

CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.

Journal: Communications biology
Published: November 12, 2024

Lipid-based nanosystems: the next generation of cancer immune therapy.

Lipid-based nanosystems: the next generation of cancer immune therapy.

Journal: Journal of hematology & oncology
Published: May 23, 2024

Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.

Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.

Journal: Nature communications
Published: April 29, 2024

TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients.

TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients.

Journal: Npj imaging
Published: September 21, 2023

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches.

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches.

Journal: Frontiers in oncology
Published: April 03, 2023

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.

Journal: Cells
Published: February 13, 2023

Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy.

Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy.

Journal: Cancers
Published: February 09, 2023

3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma Cells.

3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma Cells.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: July 20, 2022

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients.

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients.

Journal: Cancers
Published: July 15, 2022

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.

Journal: Nature communications
Published: June 17, 2022
Showing 1-12 of 30

Last Updated: 09/26/2026